PH25640A - Isoquinoline derivatives, their preparation, their use - Google Patents

Isoquinoline derivatives, their preparation, their use

Info

Publication number
PH25640A
PH25640A PH38011A PH38011A PH25640A PH 25640 A PH25640 A PH 25640A PH 38011 A PH38011 A PH 38011A PH 38011 A PH38011 A PH 38011A PH 25640 A PH25640 A PH 25640A
Authority
PH
Philippines
Prior art keywords
preparation
isoquinoline derivatives
isoquinoline
derivatives
Prior art date
Application number
PH38011A
Other languages
English (en)
Inventor
Klaus Hasspacher
Reto Naef
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH25640A publication Critical patent/PH25640A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH38011A 1988-01-08 1989-01-06 Isoquinoline derivatives, their preparation, their use PH25640A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888800397A GB8800397D0 (en) 1988-01-08 1988-01-08 Improvements in/relating to organic compounds

Publications (1)

Publication Number Publication Date
PH25640A true PH25640A (en) 1991-08-21

Family

ID=10629678

Family Applications (1)

Application Number Title Priority Date Filing Date
PH38011A PH25640A (en) 1988-01-08 1989-01-06 Isoquinoline derivatives, their preparation, their use

Country Status (28)

Country Link
US (1) US4980359A (it)
JP (1) JPH0649686B2 (it)
KR (1) KR0142686B1 (it)
AT (1) AT394365B (it)
AU (1) AU622429B2 (it)
BE (1) BE1002730A3 (it)
CA (1) CA1332944C (it)
CH (1) CH678727A5 (it)
DE (1) DE3900233C2 (it)
DK (1) DK5789A (it)
ES (1) ES2010071A6 (it)
FI (1) FI90865C (it)
FR (1) FR2625743B1 (it)
GB (2) GB8800397D0 (it)
GR (1) GR1002750B (it)
HU (1) HU205083B (it)
IE (1) IE61914B1 (it)
IL (1) IL88899A (it)
IT (1) IT1229523B (it)
LU (1) LU87423A1 (it)
MY (1) MY103963A (it)
NL (1) NL8900029A (it)
NZ (1) NZ227561A (it)
PH (1) PH25640A (it)
PL (1) PL156099B1 (it)
PT (1) PT89405B (it)
SE (1) SE501548C2 (it)
ZA (1) ZA89133B (it)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2723674A (en) * 1951-11-28 1955-11-15 Charles E Harris Telephone cableman's tent
US3007541A (en) * 1959-02-24 1961-11-07 Jr John B Mast Temporary covering and support structure therefor
GB8807922D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Isoquinoline compound & process for preparation thereof
US4956371A (en) * 1989-09-19 1990-09-11 Euroceltique, S.A. Substituted isoquinolines and methods of using same
GB8921304D0 (en) * 1989-09-20 1989-11-08 Wyeth John & Brother Ltd New method of treatment and heterocyclic compounds used therein
GB9027055D0 (en) * 1990-12-13 1991-02-06 Sandoz Ltd Organic compounds
KR930703259A (ko) * 1990-12-17 1993-11-29 알베르투스 빌헬무스 요아네스 쩨스트라텐 살균성 이소퀴놀린 유도체
CA2093577C (en) * 1992-05-07 2006-01-03 Michael Klaus Alkyl or alkoxy substituted s-heterocyclic retinoids
US5350423A (en) * 1992-09-23 1994-09-27 Burlington Industries Inc. Fabric finishing procedure
GB9322828D0 (en) * 1993-11-05 1993-12-22 Sandoz Ltd Organic compounds
PL194312B1 (pl) * 1994-12-23 2007-05-31 Smithkline Beecham Corp Przeciwciało monoklonalne neutralizujące gryzoni,linia hybrydoma, humanizowane przeciwciało, region CDR ciężkiego łańcucha immunoglobuliny, region CDR lekkiego łańcucha immunoglobuliny, cząsteczki kwasu nukleinowego, przeciwciało chimeryczne, kompozycja farmaceutyczna, izolowana sekwencja kwasu nukleinowego, rekombinowany plazmid i komórka gospodarza oraz sposób wytwarzania humanizowanego przeciwciała i sposób wspomagania diagnostyki alergii
US5683892A (en) * 1994-12-23 1997-11-04 Smithkline Beecham Corporation DNA encoding recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
US5783184A (en) * 1994-12-23 1998-07-21 Smithkline Beecham Corporation Method for treatment and diagnosis of IL-5 mediated disorders
US7399837B2 (en) * 1995-12-22 2008-07-15 Smithkline Beecham Corporation Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
GB9622386D0 (en) * 1996-10-28 1997-01-08 Sandoz Ltd Organic compounds
IT1296985B1 (it) 1997-12-19 1999-08-03 Zambon Spa Derivati benzazinici inibitori della fosfodiesterasi 4
EP1163226B1 (en) * 1999-01-15 2007-03-14 ALTANA Pharma AG Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
EP2193808A1 (en) 1999-08-21 2010-06-09 Nycomed GmbH Synergistic combination
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
EP2152310A4 (en) * 2007-04-30 2010-05-26 Glaxosmithkline Llc METHODS OF ADMINISTERING ANTI-IL-5 ANTIBODIES
BRPI0910854A2 (pt) * 2008-03-28 2015-10-06 Glaxosmithkline Llc métodos de tratamento
WO2010045342A1 (en) 2008-10-17 2010-04-22 Wisconsin Alumni Research Foundation Method of making biologically active alpha-beta peptides
JP7295038B2 (ja) 2017-06-06 2023-06-20 グラクソスミスクライン エルエルシー 小児患者のための生物薬剤組成物及び方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB645139A (en) * 1946-10-22 1950-10-25 Servita Gyogyszeryar Es Vegyip Improved process for the production of isoquinoline derivatives
DE1184344B (de) * 1962-06-16 1964-12-31 Orgamol Sa Verfahren zur Herstellung von Isochinolinderivaten
US3878215A (en) * 1971-12-01 1975-04-15 Sandoz Ag 2-Alkyl-3-substituted-4-aryl isoquinolines
DE2401453A1 (de) * 1973-01-16 1974-07-18 John James Voorhees Pharmazeutische zusammensetzung zur behandlung von hautproliferationserkrankungen
US4018927A (en) * 1973-12-17 1977-04-19 The Regents Of The University Of Michigan Treatment of proliferating skin diseases with papaverine alkaloids
SE7500859L (it) * 1974-02-05 1975-08-06 Sandoz Ag
DE2811361A1 (de) * 1978-03-16 1979-09-27 Hoechst Ag Neue isochinolinaldehyde und verfahren zu ihrer herstellung
DE3244594A1 (de) * 1982-12-02 1984-06-07 Hoechst Ag, 6230 Frankfurt 1-phenylisochinolinderivate und verfahren zu ihrer herstellung, diese verbindung enthaltende pharmazeutische praeparate und deren anwendung
HU196758B (en) * 1986-05-21 1989-01-30 Gyogyszerkutato Intezet Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them
PH25651A (en) * 1986-05-21 1991-08-21 Duphar Int Res New di, tetrahydroisoquinoline derivatives

Also Published As

Publication number Publication date
AT394365B (de) 1992-03-25
IT1229523B (it) 1991-09-04
SE8900039L (sv) 1989-07-09
FI90865C (fi) 1994-04-11
CH678727A5 (it) 1991-10-31
CA1332944C (en) 1994-11-08
PT89405B (pt) 1993-09-30
LU87423A1 (fr) 1989-08-30
PL156099B1 (pl) 1992-02-28
SE8900039D0 (sv) 1989-01-05
JPH01213267A (ja) 1989-08-28
MY103963A (en) 1993-10-30
NZ227561A (en) 1991-11-26
FR2625743B1 (fr) 1990-11-09
GR1002750B (el) 1997-08-26
JPH0649686B2 (ja) 1994-06-29
PT89405A (pt) 1990-02-08
IE61914B1 (en) 1994-11-30
ES2010071A6 (es) 1989-10-16
GR890100008A (el) 1994-03-31
FI90865B (fi) 1993-12-31
DK5789D0 (da) 1989-01-06
GB8800397D0 (en) 1988-02-10
US4980359A (en) 1990-12-25
HU205083B (en) 1992-03-30
DE3900233C2 (de) 2000-04-27
BE1002730A3 (fr) 1991-05-21
ZA89133B (en) 1990-09-26
SE501548C2 (sv) 1995-03-13
IL88899A0 (en) 1989-08-15
GB8900102D0 (en) 1989-03-01
GB2213482B (en) 1991-09-11
DE3900233A1 (de) 1989-07-20
FI890072A0 (fi) 1989-01-06
FI890072A (fi) 1989-07-09
DK5789A (da) 1989-07-09
AU2779589A (en) 1989-07-20
GB2213482A (en) 1989-08-16
KR0142686B1 (ko) 1998-07-15
IL88899A (en) 1994-07-31
KR890011851A (ko) 1989-08-22
HUT52061A (en) 1990-06-28
ATA3589A (de) 1991-09-15
IT8947504A0 (it) 1989-01-04
NL8900029A (nl) 1989-08-01
PL277092A1 (en) 1989-09-04
FR2625743A1 (fr) 1989-07-13
IE890037L (en) 1989-07-08
AU622429B2 (en) 1992-04-09

Similar Documents

Publication Publication Date Title
PH25640A (en) Isoquinoline derivatives, their preparation, their use
EP0232989A3 (en) Isoquinoline derivatives
PH25651A (en) New di, tetrahydroisoquinoline derivatives
GB2222828B (en) Butynylamine derivatives
EG19385A (en) N-phenylpyrazol -4-yl-ether derivatives
ZA879235B (en) Peridone derivatives,and their preparation and use
GB2222829B (en) Benzylidenecyclanone derivatives
IL92281A0 (en) Polyimidesiloxanes,their preparation and use
ZA857272B (en) Vinyltetrazolylphenyl derivatives,their preparation and their use
EP0355353A3 (en) Cycloalkylthiazole derivatives
GB2195636B (en) Isoquinoline derivatives
EP0352083A3 (en) Alkenyltetrazole derivatives, their preparation and use
GB2194532B (en) Isoquinoline derivatives
ZA873637B (en) Isoquinoline derivatives
ZA875592B (en) Isoquinoline derivatives
IL80010A0 (en) 1-amino-3-phenylpropan-2-ol derivatives,their preparation and their use as microbicides
IL81718A0 (en) Aromatic-omega-alkylimino-tetra-hydro-6h-1,3-thiazin-6-one derivatives
ZA907628B (en) 3-isoxazolone derivatives,their preparation and their therapeutic uses
IL84609A0 (en) Isoquinoline derivatives
ZW888A1 (en) Isoquinoline derivatives
ZA891416B (en) Tetrahydroisoquinoline derivatives
IE890576L (en) Tetrahydroisoquinoline derivatives
AU7202587A (en) Isoquinoline derivatives, their manufacture and use
ZA878935B (en) Isoquinoline derivatives
IE873208L (en) Isoquinoline derivatives.